Cargando…

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

Cisplatin resistance is a major challenge in the clinical treatment of ovarian cancer, of which the underlying mechanisms remain unknown. The aim of the present study was to explore the role of autophagy in cisplatin resistance in ovarian cancer cells. A2780cp cisplatin-resistant ovarian carcinoma c...

Descripción completa

Detalles Bibliográficos
Autores principales:	BAO, LINGJIE, JARAMILLO, MELBA C., ZHANG, ZHENBO, ZHENG, YUNXI, YAO, MING, ZHANG, DONNA D., YI, XIAOFANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237096/ https://www.ncbi.nlm.nih.gov/pubmed/25322694 http://dx.doi.org/10.3892/mmr.2014.2671

Ejemplares similares

Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells
por: Wu, Jianfa, et al.
Publicado: (2017)

Increased Autophagy Levels Mediate Cisplatin Resistance in Cisplatin-Resistant Cells While Also Rendering Them Vulnerable to Autophagy Induction
por: Duan, Guihua, et al.
Publicado: (2018)

TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer
por: Tan, Wen-Xi, et al.
Publicado: (2019)

Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780)
por: Jafarzadeh, Samira, et al.
Publicado: (2021)

MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy
por: Cai, Yi, et al.
Publicado: (2021)

ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells
por: Xiao, Lan, et al.
Publicado: (2016)

Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
por: Zhou, Fuxing, et al.
Publicado: (2018)

Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
por: Zaffaroni, N., et al.
Publicado: (1998)

The emerging role of the Nrf2–Keap1 signaling pathway in cancer
por: Jaramillo, Melba C., et al.
Publicado: (2013)

Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer
por: Wang, Huan, et al.
Publicado: (2022)

Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties
por: Wang, Huan, et al.
Publicado: (2023)

MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy
por: Li, Meng, et al.
Publicado: (2023)

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
por: Haslehurst, Alexandria M, et al.
Publicado: (2012)

IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
por: Zhu, Xiaolan, et al.
Publicado: (2017)

Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway
por: Xiao, Lan, et al.
Publicado: (2021)

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
por: Zhao, Fuguang, et al.
Publicado: (2020)

Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway
por: WANG, TIAN, et al.
Publicado: (2014)

UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance
por: Jin, Chengmeng, et al.
Publicado: (2013)

The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
por: Im-aram, Akechai, et al.
Publicado: (2013)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
por: Dou, Lei, et al.
Publicado: (2021)

Upregulation of FOXO1 contributes to lipopolysaccharide-induced pulmonary endothelial injury by induction of autophagy
por: Zhao, Ying, et al.
Publicado: (2022)

Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin
por: Huang, Wei, et al.
Publicado: (2021)

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
por: Zhou, Yang, et al.
Publicado: (2022)

The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer
por: Zheng, Zhi-Guo, et al.
Publicado: (2016)

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019)

BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
por: Jia, Jinghui, et al.
Publicado: (2020)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
por: Zheng, Wujian, et al.
Publicado: (2017)

Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
por: Xu, Lei, et al.
Publicado: (2021)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Effects of Electroacupuncture on the Gut Microbiome in Cisplatin-Induced Premature Ovarian Failure Mice
por: He, Qi-da, et al.
Publicado: (2022)

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
por: Wang, Yiying, et al.
Publicado: (2016)

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
por: Liu, Yixuan, et al.
Publicado: (2021)

Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion
por: Wang, Haixia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qp815eacgq473108ubnhop8mrn